Perceptive Advisors’s La Jolla Pharmaceutical LJPC Stock Holding History
Bought
Maintained
Sold
Other funds holding LJPC
BBA
Perceptive Advisors's LJPC Position: Q1 2019 in Review
Perceptive Advisors sold out of La Jolla Pharmaceutical (LJPC) in Q1 2019, closing a stake of 4,313,611 shares — an estimated $41M sold.
Perceptive Advisors first reported a position in LJPC in Q3 2014 and held it in 18 quarters. The position peaked at $128M in Q1 2018. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.
- Perceptive Advisors reported no remaining La Jolla Pharmaceutical position as of Q1 2019 after selling out during the quarter.
- Perceptive Advisors sold 4,313,611 La Jolla Pharmaceutical shares in Q1 2019, an estimated $41M.
- Perceptive Advisors first reported a position in La Jolla Pharmaceutical in Q3 2014 and held it in 18 quarters.
- Perceptive Advisors's La Jolla Pharmaceutical position peaked at $128M in Q1 2018.
- 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical as of Q1 2019.
Based on Perceptive Advisors's 13F filing for Q1 2019, filed 15 May 2019.